Cervomed Inc CRVO

$1.69 -0.14 (-7.65%)

Valuation

Market cap
27,686,000
Revenue TTM
$4,010,000
Net income TTM
$-26,970,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-672.57%
Debt to equity
0.00

Trading

Volume
639,900
Avg volume
542,382
Day's range
$1.64 – $1.79
Shares out
15,129,000
Stochastic %K
45%
Beta
-0.62
Analysts
Strong Buy
Price target
$17.83

Price

Company profile

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease...

Show more

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.

Industry
Biotechnology
Sector
Healthcare
Phone
617 744 4400
Website
https://www.cervomed.com
Address
20 Park Plaza, Suite 424, Boston, United States

Latest news

Stocktwits

DrNeega Nov 13, 5:26 PM
$CRVO this thing is primed to explode
0 replies
5layer Nov 13, 1:45 PM
$CRVO another green day?
1 replies
URANIUM77 Nov 12, 7:54 PM
$SEGG $OMH $CRVO Sports Entertainment Gaming Global Corporation ($SEGG) CTB from 15% — one week later — 700%; that is a massive 3,500% increase. https://fintel.io/ss/us/segg
1 replies
Houseofsweeps Nov 12, 6:40 PM
$CRVO the long time holders right now 😂🤣 I miss the fuck ya mother guy
1 replies
LebanesePrince Nov 12, 6:39 PM
$CRVO insiders are dropping big bags of money. It doesn’t spike like that for no reason the news is out it’s been leaked and they’re dropping big bags.
1 replies
Aye_Sir Nov 12, 6:19 PM
$CRVO damn i dumped my shares as it went red
0 replies
LebanesePrince Nov 12, 6:16 PM
$CRVO wowwwww get ready
0 replies
walker7782 Nov 12, 5:31 PM
$CRVO Sabby doing what they do best today…Textbook arb-desk distribution. Sabby & Armistice entered during the mid-2026 financings and are using pre-CTAD (Nov 16–19) retail momentum as exit liquidity. Every push over $2.00 ($2.17 high today) gets sold and delta-hedged by algos, walking it right back to $1.73. They aren't holding for Phase 3—they're harvesting volatility ahead of the next cash raise. Until Hal eats, this is it.
3 replies